Hillen HF - Search Results

1

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.

Simons JP, Aaronson NK, Vansteenkiste JF, ten Velde GP, Muller MJ, Drenth BM, Erdkamp FL, Cobben EG, Schoon EJ, Smeets JB, Schouten HC, Demedts M, Hillen HF, Blijham GH, Wouters EF. Simons JP, et al. Among authors: hillen hf. J Clin Oncol. 1996 Apr;14(4):1077-84. doi: 10.1200/JCO.1996.14.4.1077. J Clin Oncol. 1996. PMID: 8648360 Clinical Trial.

2

Prognostic and predictive factors in breast cancer.

Jansen RL, Hillen HF, Schouten HC. Jansen RL, et al. Among authors: hillen hf. Neth J Med. 1997 Aug;51(2):65-77. doi: 10.1016/s0300-2977(97)00021-1. Neth J Med. 1997. PMID: 9286143 Review. No abstract available.

3

The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer.

Hupperets PS, Volovics L, Schouten LJ, Jager JJ, Schouten HC, Hillen HF, Blijham GH. Hupperets PS, et al. Among authors: hillen hf. Am J Clin Oncol. 1997 Dec;20(6):546-51. doi: 10.1097/00000421-199712000-00002. Am J Clin Oncol. 1997. PMID: 9391537

4

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer.

Lalisang RI, Voest EE, Wils JA, Nortier JW, Erdkamp FL, Hillen HF, Wals J, Schouten HC, Blijham GH. Lalisang RI, et al. Among authors: hillen hf. Br J Cancer. 2000 Jun;82(12):1914-9. doi: 10.1054/bjoc.2000.1202. Br J Cancer. 2000. PMID: 10864197 Free PMC article. Clinical Trial.

5

Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP).

Dubbeld P, Hillen HF, Schouten HC. Dubbeld P, et al. Among authors: hillen hf. Eur J Haematol. 1994 Apr;52(4):233-5. doi: 10.1111/j.1600-0609.1994.tb00651.x. Eur J Haematol. 1994. PMID: 8005234 Clinical Trial.

6

CD44v6 is not a prognostic factor in primary breast cancer.

Jansen RH, Joosten-Achjanie SR, Arends JW, Volovics A, Hupperets PS, Schouten HC, Hillen HF. Jansen RH, et al. Among authors: hillen hf. Ann Oncol. 1998 Jan;9(1):109-11. doi: 10.1023/a:1008220917687. Ann Oncol. 1998. PMID: 9541692 Free article. Clinical Trial.

7

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.

Jansen RL, Joosten-Achjanie SR, Volovics A, Arends JW, Hupperets PS, Hillen HF, Schouten HC. Jansen RL, et al. Among authors: hillen hf. Anticancer Res. 1998 Nov-Dec;18(6A):4455-62. Anticancer Res. 1998. PMID: 9891509

8

pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer.

Jansen RL, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Hillen HF, Schouten HC. Jansen RL, et al. Among authors: hillen hf. Anticancer Res. 1998 Jan-Feb;18(1B):577-82. Anticancer Res. 1998. PMID: 9568180

9

MIB-1 labelling index is an independent prognostic marker in primary breast cancer.

Jansen RL, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Schouten HC, Hillen HF. Jansen RL, et al. Among authors: hillen hf. Br J Cancer. 1998 Aug;78(4):460-5. doi: 10.1038/bjc.1998.515. Br J Cancer. 1998. PMID: 9716027 Free PMC article.

10

Thrombosis in cancer patients.

Hillen HF. Hillen HF. Ann Oncol. 2000;11 Suppl 3:273-6. doi: 10.1093/annonc/11.suppl_3.273. Ann Oncol. 2000. PMID: 11079152 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page